Precision cell line controls with AI optimization

Improving antibody optimization and IHC assessment

PCI has years of experience in cell line characterization and biomarker quality control.

We aim to improve patient care by improving precision with cell line IHC control panels and AI assessment assistance.

PCI's Products and Services

Cell line IHC quality controls

TriControl, Quadcontrol and Dualcontrol cell line IHC control panels with AI-use potential.

Biomarker AI

Biomarker AI assistance applications to decrease interpretation time.

Digital pathology education

Explore digital pathology cases with annotations and supporting videos

PCI’s TriControl, QuadControl™, and DualControl™ cell line panels are designed to enrich biomarker antibody optimization and decrease time for IHC assessment.

TriControl panels

Three cell lines painstakingly selected to present a spectrum of null (absent), wild type (normal) and diffuse (overexpression).


DualControl™ and single control panels

One or two cell lines are painstakingly selected to present normal expression and deficient expression or only Overexpression, wild type expression or null type expression. Additionally, we provide cell lines for normal and positive viral load


QuadControl panels

Four cell lines painstakingly selected to present a spectrum of null (absent), low wild type (low normal), high wild type (high normal), and diffuse (overexpression). Our MMR QuadControl™ assists with mismatch repair protein antibody optimization and assessment


AI assessment service

We developed AI algorithms to enrich biomarker assessment and decrease time spent on evaluation. Ask us about how we can help you directly.


PCI is driven to provide the highest quality cell line controls focusing on assisting pathologists/histologists' assessment and decreasing the time spent on individual evaluations. We understand that your time is valuable and case loads can be demanding. Let us optimize your antibody quality control evaluation and reduce the time spent on individual IHC assessments.